Sleep Habits and Their Impact on Alzheimer’s Risk: New Insights
A recent study reveals how sleep habits may influence the genetic risk of developing Alzheimer’s disease, highlighting the importance of sleep quality.

Recent research has highlighted the significant role that sleep habits may play in the risk of developing Alzheimer’s disease. A team of Australian scientists has found that certain sleep patterns can influence how genetic factors contribute to brain health.
The study, published in the journal Alzheimer's and Dementia, focuses on a gene known as aquaporin-4 (AQP4), which is crucial for the brain's waste clearance system during sleep. This research suggests that the genetic predisposition for Alzheimer’s is not entirely fixed from birth, as sleep quality can alter the effects of specific genetic variations.
Genetic Risk Factors and Sleep Quality
Researchers from Edith Cowan University examined 351 older adults, averaging 75 years of age, who were part of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. All participants began with normal memory function but exhibited significant levels of amyloid beta, an early indicator of Alzheimer’s risk, as revealed through imaging scans.
The participants completed standardized questionnaires about their sleep habits, including duration and quality, and underwent detailed cognitive testing alongside MRI and PET scans. The study analyzed 13 common variants of the AQP4 gene to determine their relationship with brain volume and cognitive performance, particularly in relation to sleep quality.

The findings indicated that one specific genetic variant, known as rs162007, correlated with better memory and cognitive scores at the study's outset, regardless of sleep habits.
The Glymphatic System and Its Importance
In a healthy brain, the glymphatic system functions like internal plumbing, circulating cerebrospinal fluid to flush out amyloid beta and other waste during sleep. The AQP4 protein, found on astrocytes, facilitates this cleansing process, which is most effective during deep sleep. Insufficient deep sleep can lead to the accumulation of toxic proteins, heightening the risk of Alzheimer’s-related damage over time.
The interplay between genetics and sleep emerged as a crucial factor. For certain AQP4 variants (specifically rs151245 and rs2339214), shorter sleep duration was linked to a more rapid decline in gray matter over the years. Ayeisha Milligan Armstrong, one of the researchers, noted, "Our study shows that individuals with specific AQP4 variants experienced faster gray matter loss when they reported shorter sleep durations."
Implications of Short Sleep Duration
Additionally, the study examined the brain's ventricles, which expand as surrounding tissue shrinks. A prolonged time to fall asleep was associated with larger ventricles in carriers of the variant rs7240333, while poor sleep quality was linked to faster ventricular enlargement in those with rs2339214. Another variant, rs68006382, was associated with reduced white matter volumes as sleep duration increased.
"This is significant because sleep is one of the few modifiable factors that people can actively manage," Armstrong emphasized.
Interestingly, some rare genetic profiles (rs12968026 and rs3875089) appeared to offer a protective effect, where increased nighttime awakenings correlated with slower cognitive decline.
Tenielle Porter, another researcher involved in the study, remarked, "We have known for some time that poor sleep is associated with Alzheimer’s risk. This study suggests that instead of assuming all at-risk individuals follow the same trajectory, a more tailored and personalized approach to Alzheimer’s prevention may be necessary."
Despite these insights, the researchers did not find a clear connection between the AQP4 variants and the progression of amyloid beta levels over the study period, indicating that significant effects might occur much earlier in life. While the observed differences in brain volumes and cognitive performance were modest and not predictive of individual outcomes, the team cautioned against recommending genetic testing at this stage. Porter noted, "Our results need to be replicated in larger and more diverse cohorts."



